Regence Health Policy Center

30/11/2023

Earlier this month, Portland played host to Oregon’s 2023 State of Reform Conference.

What were the key takeaways?

➡️ Check out the HPC’s most recent publication, recapping the key themes from the event including access and workforce, social drivers of health, Medicaid innovations, and a presentation from Regence’s Director of Medical Policy, Heidi Kriz, on data integration and interoperability.

The Regence Health Policy Center informs, debates and advances policies that promote an affordable, accessible and person-focused health care system.

10/02/2023

When Pharma’s drug affordability answer is a coupon that hides the true cost of the medications, it’s worth questioning how much of the solution benefits the patient and not just corporate profits.

https://regencehpc.com/publications/drug-manufacturers-billion-dollar-scheme

09/02/2023

When Pharma’s drug affordability answer is a coupon that masks their double-digit price increases, it’s worth questioning how much of the solution benefits the patient and not just corporate profits.

09/02/2023

Pharma’s multi-million dollar scheme revealed:

When a program guarantees enormous profits for drug manufacturers but will secretly cost employers, families, and health plans millions of dollars, it’s time we see what (and who) is behind the solution.

https://regencehpc.com/publications/drug-manufacturers-billion-dollar-scheme

The Regence Health Policy Center informs, debates and advances policies that promote an affordable, accessible and person-focused health care system.

01/12/2022

What were the main takeaways from our first virtual event?

Rewatch, Improving Drug Affordability: The Promise of Biosimilars, to learn the differences between biosimilars and biologics, how biosimilars could be an answer to rising costs and what policymakers can do to advance greater adoption.

Click here to rewatch the event: https://regencehpc.com/publications/improving-drug-affordability-the-promise-of-biosimilars

The Regence Health Policy Center informs, debates and advances policies that promote an affordable, accessible and person-focused health care system.

23/11/2022

Improving Drug Affordability: The Promise of Biosimilars is less than one week away! ⏰

Don't miss our first virtual event where we host four experts to address the rising costs of and explore the policy solutions that can accelerate the adoption of biosimilars.

What potential do biosimilars have to drastically reduce drug spending in ?

Find out next Tuesday!

➡️ Register here: https://www.eventbrite.com/e/improving-drug-affordability-the-promise-of-biosimilars-tickets-457774785707

Join the Regence Health Policy Center as we explore the future and promise of biosimilars advancing prescription drug affordability.

09/11/2022

With the cost of on the rise, what are the underlying incentives to oppose drug acquisition methods like to acquire specialty drugs?

In our most recent publication, we address the importance of alternative drug acquisition methods to advance affordable prescription drugs and reveal the hidden reasons why some stakeholders may oppose these programs.

Check out our most recent article as we explore:
• A 101 understanding on the various methods to acquire specialty drugs
• The hidden financial incentives of opposing certain drug acquisition programs
• What legislators and regulators should consider when advancing affordable, accessible specialty drugs

https://regencehpc.com/publications/what-s-in-the-bag-revealing-hospital-s-excessive-markups-on-specialty-drugs

The Regence Health Policy Center informs, debates and advances policies that promote an affordable, accessible and person-focused health care system.

26/10/2022

How are copay coupons secretly costing employers, unions, and health plans billions of dollars?

According to the Pharmaceutical Care Management Association, continued utilization of copay coupons is projected to cost employers, unions and health plans nearly $32 billion over a 10-year period.

In our most recent article, we reveal how the hidden motivations and strategies of copay coupon programs distract from the rise of prescription drug prices and conceal manufacturers’ financial incentives.

Learn more here: https://regencehpc.com/publications/drug-manufacturers-billion-dollar-scheme

The Regence Health Policy Center informs, debates and advances policies that promote an affordable, accessible and person-focused health care system.

17/10/2022

Which innovations and services are (re)-shaping the future of ?

Since the pandemic, the increased utilization of telehealth, home-based care services and other emerging innovations are redefining health care delivery and coordination.

➡️ Join the Regence Health Policy Center team next Tuesday, October 25th, as we sponsor the 2022 Oregon State of Reform Conference in Portland, Oregon.

☑️ Don’t miss your chance to hear from Dr. Jim Polo, Executive Medical Director for Regence BlueCross BlueShield, and other experts on the lessons learned from the pandemic and the innovations that will continue to be used in a post-COVID world.

➡️ Register here: https://stateofreform.com/conference/2022-oregon-state-of-reform-health-policy-conference/detailed-agenda/

Our 2022 Oregon State of Reform Health Policy Conference Detailed Agenda is a list of nearly 50 speakers and experts from across the spectrum of care.